LifeMD Inc [LFMD] stock is trading at $1760000.0, up 2856516%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LFMD shares have gain 16.22% over the last week, with a monthly amount glided 38.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeMD Inc [NASDAQ: LFMD] stock has seen the most recent analyst activity on June 18, 2025, when BTIG Research reiterated its Buy rating and also boosted its price target to $18 from $15. Previously, Lake Street started tracking the stock with Buy rating on December 10, 2024, and set its price target to $12. On December 04, 2024, Mizuho initiated with a Neutral rating and assigned a price target of $7 on the stock. KeyBanc Capital Markets initiated its recommendation with a Overweight and recommended $12 as its price target on June 05, 2024. Craig Hallum started tracking with a Buy rating for this stock on November 30, 2023, and assigned it a price target of $10. In a note dated July 21, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $7 on this stock.
LifeMD Inc [LFMD] stock has fluctuated between $3.99 and $15.29 over the past year. Currently, Wall Street analysts expect the stock to reach $10.5 within the next 12 months. LifeMD Inc [NASDAQ: LFMD] shares were valued at $1760000.0 at the most recent close of the market. An investor can expect a potential drop of -100.0% based on the average LFMD price forecast.
Analyzing the LFMD fundamentals
LifeMD Inc [NASDAQ:LFMD] reported sales of 234.01M for the trailing twelve months, which represents a growth of 48.83%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at -0.04%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is 2.33 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-10.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, LifeMD Inc’s Current Ratio is 0.82. Also, the Quick Ratio is 0.77, while the Cash Ratio stands at 0.56. Considering the valuation of this stock, the price to sales ratio is 2.87.
Transactions by insiders
Recent insider trading involved Benathen Marc David, Chief Financial Officer, that happened on Jun 16 ’25 when 75000.0 shares were sold. Chief Financial Officer, Benathen Marc David completed a deal on Jun 17 ’25 to sell 50000.0 shares. Meanwhile, Chief Legal Officer & GC Yecies Eric Harold sold 15000.0 shares on Jun 13 ’25.
